Usefulness of LDAEP to predict tolerability to SSRIs in major depressive disorder: A case report

Psychiatry Investigation

Volumn 9, Issue 1, 2012, Pages 80-82

  Park, Young Min ^a   Lee, Seung Hwan ^a,b   Park, Eun Jin ^a  

^a Inje University College of Medicine   (South Korea)

^b Clinical Emotion and Cognition Research Laboratory   (South Korea)

Author keywords

LDAEP; SSRI; Tianeptine; Tolerability; Treatment response

Indexed keywords

CLONAZEPAM; ESCITALOPRAM; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE;

AKATHISIA; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CASE REPORT; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVOKED AUDITORY RESPONSE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; LOUDNESS DEPENDENT OF AUDITORY EVOKED POTENTIAL; MAJOR DEPRESSION; MALE; NAUSEA; NEUROTRANSMISSION; OUTPATIENT; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; SIDE EFFECT; VOMITING; WEAKNESS;

EID: 84863269075     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2012.9.1.80     Document Type: Article

References (12)

1. Strobel A, Debener S, Schmidt D, Hünnerkopf R, Lesch KP, Brocke B. Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 2003;118B:41-47.
2. Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, Möller HJ, et al. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 2003;64:115-124.
3. Hegerl U, Gallinat J, Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 2001;62:93-100.
4. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 2000;148:404-411.
5. Linka T, Sartory G, Bender S, Gastpar M, Müller BW. The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences. J Affect Disord 2007;103:139-145.
6. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993;33:173-187.
7. Park YM, Lee SH, Kim S, Bae SM. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:313-316.
8. Juckel G, Pogarell O, Augustin H, Mulert C, Muller-Siecheneder F, Frodl T, et al. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 2007;68:1206-1212.
9. Park YM, Kim DW, Kim S, Im CH, Lee SH. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology (Berl) 2011;213:625-632.
10. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 2006;21:47-52.
11. Kasper S, McEwen BS. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs 2008;22:15-26.
12. Uzbay TI. Tianeptine: potential influences on neuroplasticity and novel pharmacological effects. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:915-924.